-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Initiates Coverage On Vor Biopharma with Overweight Rating, Announces Price Target of $43

Benzinga·12/09/2025 12:09:34
語音播報
JP Morgan analyst Anupam Rama initiates coverage on Vor Biopharma (NASDAQ:VOR) with a Overweight rating and announces Price Target of $43.